Contraception
📧 Sign up to get email alerts when something new happens for Contraception.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-04-29FDA Approved: NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for the norethindrone/ethinyl estradiol/ferrous fumarate oral contraceptive manufactured by Mylan Ph…
-
FDA approval · 2022-04-29FDA Approved: ISIBLOOM — Supplemental Application (Xiromed, LLC.)
The FDA approved a supplemental application for ISIBLOOM, a desogestrel and ethinyl estradiol oral contraceptive from Xiromed, LLC.
-
FDA approval · 2022-04-29FDA Approved: FEMYNOR — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approves a supplemental application for FEMYNOR, a generic oral contraceptive containing norgestimate and ethinyl estradiol, from Amneal…
-
FDA approval · 2022-04-29FDA Approved: BLISOVI 24 FE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for BLISOVI 24 FE, a combined oral contraceptive containing norethindrone acetate and ethinyl es…
-
FDA approval · 2022-04-29FDA Approved: ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Ethynodiol diacetate and ethinyl estradiol by Mylan Pharmaceuticals, a combined oral contracepti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-04-29FDA Approved: TRI-LO-MILI — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for TRI-LO-MILI (norgestimate and ethinyl estradiol) by Aurobindo Pharma Limited.
-
FDA approval · 2022-04-29FDA Approved: TARINA 24 FE — Supplemental Application (Afaxys Pharma, LLC)
FDA approved a supplemental application for Tarina 24 FE, a combination oral contraceptive, to Afaxys Pharma LLC.
-
FDA approval · 2022-04-29FDA Approved: BALZIVA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for BALZIVA (norethindrone and ethinyl estradiol) from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2022-04-29FDA Approved: BALCOLTRA — Supplemental Application (Avion Pharmaceuticals)
FDA approved a supplemental application for BALCOLTRA (levonorgestrel and ethinyl estradiol) submitted by Avion Pharmaceuticals.
-
FDA approval · 2022-04-29FDA Approved: NEXTSTELLIS — Supplemental Application (Mayne Pharma)
The FDA approved a supplemental application for Nextstellis (DROSPIRENONE AND ESTETROL) filed by Mayne Pharma.
-
FDA approval · 2022-04-29FDA Approved: FALMINA — Supplemental Application (Northstar Rx LLC)
FDA approved a supplemental application for Falmina, a combined oral contraceptive containing levonorgestrel and ethinyl estradiol, submitte…
-
FDA approval · 2022-04-29FDA Approved: NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE — Supplemental Application (Naari Pte Limited)
FDA approved a supplemental application for a combined oral contraceptive tablet containing norethindrone, ethinyl estradiol, and ferrous fu…
-
FDA approval · 2022-04-29FDA Approved: CRYSELLE — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approved a supplemental application for CRYSELLE (norgestrel and ethinyl estradiol) from Teva Pharmaceuticals, updating the labeling via…
-
FDA approval · 2022-04-29FDA Approved: HAILEY 24 FE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for HAILEY 24 FE, a generic combined oral contraceptive containing norethindrone acetate and ethinyl…
-
FDA approval · 2022-04-29FDA Approved: NORELGESTROMIN AND ETHINLY ESTRADIOL — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved a supplemental application for the generic combined oral contraceptive product NORELGESTROMIN AND ETHINLY ESTRADIOL from Am…
-
FDA approval · 2022-04-29FDA Approved: VYLIBRA — Supplemental Application (Afaxys Pharma, LLC)
FDA approved a supplemental application for VYLIBRA (norgestimate and ethinyl estradiol) from Afaxys Pharma, LLC.
-
FDA approval · 2022-04-29FDA Approved: CYRED EQ — Supplemental Application (Afaxys Pharma, LLC)
The FDA approved a supplemental application for CYRED EQ (desogestrel and ethinyl estradiol) from Afaxys Pharma, LLC. The product is a combi…
-
FDA approval · 2022-04-29FDA Approved: LEVONORGESTREL AND ETHINYL ESTRADIOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic Levonorgestrel and Ethinyl Estradiol product from Mylan Pharmaceuticals under the …
-
FDA approval · 2022-04-29FDA Approved: ALTAVERA — Supplemental Application (Xiromed, LLC.)
FDA approved a supplemental application for ALTAVERA, a generic combined oral contraceptive containing levonorgestrel and ethinyl estradiol,…
-
FDA approval · 2022-04-22FDA Approved: CHATEAL EQ — Supplemental Application (Afaxys Pharma, LLC)
FDA approved a supplemental application for CHATEAL EQ, a combined oral contraceptive containing levonorgestrel and ethinyl estradiol, submi…
-
FDA approval · 2022-03-04FDA Approved: LEVONORGESTREL AND ETHINYL ESTRADIOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for LEVONORGESTREL AND ETHINYL ESTRADIOL submitted by Mylan Pharmaceuticals Inc., resulting in an ap…
-
FDA approval · 2022-03-03FDA Approved: MICROGESTIN 24 FE — Supplemental Application (Mayne Pharma Inc.)
FDA approved a supplemental application for MICROGESTIN 24 FE (norethindrone acetate/ethinyl estradiol and ferrous fumarate) from Mayne Phar…
-
FDA approval · 2022-02-28FDA Approved: LOW-OGESTREL — Supplemental Application (Mayne Pharma Inc.)
The FDA approved a supplemental application for Low-Ogestrel, a combined oral contraceptive containing norgestrel and ethinyl estradiol, fro…
-
FDA approval · 2022-02-22FDA Approved: NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL — Supplemental Application (Nivagen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for norethindrone acetate and ethinyl estradiol submitted by Nivagen Pharmaceuticals, Inc. The a…
-
FDA approval · 2022-02-16FDA Approved: JUNEL FE 24 — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for JUNEL FE 24, a combined oral contraceptive containing norethindrone acetate and ethinyl estr…